MedTrace Logo

The Study of the Effectiveness of Tissue Equivalent on the Basis of Cultured Cells to Heal Skin Blemishes

NCT01884831 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2013-12-12

No results posted yet for this study

Summary

In Russia the treatment nonhealing skin defects often limited to surgical interventions, despite having developed modern methods of treatment of non-healing ulcers and other skin imperfections. During the many years of research we have developed a skin equivalent comprising living cells.

During pilot trial showed that the skin equivalent provides healing skin defect within 1-4 weeks in 95% of patients.

Conditions

  • Neurotrophic Ulcers
  • Burns

Interventions

BIOLOGICAL

study of the efficacy of skin equivalent comprising living cells and skin biodegradable substrate for the treatment of skin lesions

Sponsors & Collaborators

  • Ural State Medical University

    lead OTHER

Principal Investigators

  • Oleg G Makeev, MD · Ural State Medical University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2017-07-31
Completion
2018-07-31

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01884831 on ClinicalTrials.gov